Conba estimates that its net profit in the first quarter of 2023 is projected to be 254-305 million yuan, up 150%-200% year-on-year. In the first quarter of 2023, the increase in profit brought about by the growth of the company's main business income and the impact of changes in the market value of the company's shares in Jiahe Biotech listed on the Hong Kong Stock Exchange added 98 million yuan year-on-year.